These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30203132)

  • 1. Role of pentamer complex-specific and IgG subclass 3 antibodies in HCMV hyperimmunoglobulin and standard intravenous IgG preparations.
    Schampera MS; Arellano-Galindo J; Kagan KO; Adler SP; Jahn G; Hamprecht K
    Med Microbiol Immunol; 2019 Feb; 208(1):69-80. PubMed ID: 30203132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
    Schampera MS; Schweinzer K; Abele H; Kagan KO; Klein R; Rettig I; Jahn G; Hamprecht K
    J Clin Virol; 2017 May; 90():40-45. PubMed ID: 28342316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M; Herbener P; Schüttrumpf J
    Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
    Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
    Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
    Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
    J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.
    Fouts AE; Chan P; Stephan JP; Vandlen R; Feierbach B
    J Virol; 2012 Jul; 86(13):7444-7. PubMed ID: 22532696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies.
    Ai Y; Wu C; Zhang M; Jaijyan DK; Liu T; Zan L; Li N; Yu W; Wang Y; Yuan X; Li C; Zheng W; Zhu H; Liao HX
    Microbiol Spectr; 2022 Dec; 10(6):e0139322. PubMed ID: 36342276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
    J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
    Aiba N; Shiraki A; Yajima M; Oyama Y; Yoshida Y; Ohno A; Yamada H; Takemoto M; Daikoku T; Shiraki K
    Viral Immunol; 2017 Sep; 30(7):500-507. PubMed ID: 28598267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
    Chiuppesi F; Kaltcheva T; Meng Z; Barry PA; Diamond DJ; Wussow F
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
    Weber B; Braun W; Cinatl J; Doerr HW
    Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
    Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
    Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
    McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
    Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes.
    Shibamura M; Yoshikawa T; Yamada S; Inagaki T; Nguyen PHA; Fujii H; Harada S; Fukushi S; Oka A; Mizuguchi M; Saijo M
    Virol J; 2020 Aug; 17(1):120. PubMed ID: 32746933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts.
    Reuter N; Kropff B; Britt WJ; Mach M; Thomas M
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.